Insider Shareholders with Direct Ownership of Ab Cellera Biologics Inc. (ABCL)
This section provides a comprehensive overview of the insiders with direct ownership of Ab Cellera Biologics Inc. (ABCL). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
AbCellera Biologics Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Thermopylae Holdings Ltd.
> 10% Shareholder |
2,761,679 | 6,164,420 | 55,800,009 $159 Million | 14 |
Dec 04, 2024
Reduced 0.51%
|
|
Veronique Lecault
Chief Operating Officer |
1,456,789 | 0 | 2,123,456 $6.05 Million | 9 |
Jun 21, 2024
Added 3.78%
|
|
Carl L. G. Hansen
Chief Executive Officer |
898,000 | 0 | 898,000 $2.56 Million | 13 |
Nov 25, 2024
Added 5.88%
|
|
Ester Falconer
Chief Technology Officer |
1,875,000 | 1,000,000 | 875,000 $2.49 Million | 3 |
Sep 01, 2021
Added 50.0%
|
|
Andrew Booth
Chief Financial Officer |
1,903,000 | 1,250,000 | 153,000 $436,050 | 8 |
May 26, 2023
Added 8.66%
|
|
John Hamer
Director |
0 | 300,000 | 128,862 $367,256 | 2 |
Sep 01, 2021
Reduced 51.59%
|
|
Andrew Lo
Director |
86,938 | 0 | 86,938 $247,773 | 1 |
Dec 03, 2021
Added 50.0%
|
|
John S. Montalbano
Director |
86,000 | 0 | 86,000 $245,100 | 6 |
Nov 08, 2023
Added 10.42%
|
|
Tryn Stimart
Chief Legal Officer |
1,000,250 | 1,000,000 | 250 $712 | 3 |
Jun 09, 2021
Reduced 99.98%
|